Home > Heart Valve Disease and Pregnancy
Women who have a heart valve disease and want to become pregnant have some special
considerations. A valve disease may increase the risk
to the mother and the developing baby (fetus). Treatment of a valve disease might have to change during a pregnancy.
How much a heart valve disease increases risks during pregnancy depends on the type of valve disease and how bad it is.
If you have a heart valve disease and are considering pregnancy, talk with your doctors.
Heart valve problems that may increase the risk of problems during pregnancy include:
You already have a replaced valve, and you take warfarin. Talk with your doctor if you plan on getting pregnant. You likely will not take warfarin if you are trying to get pregnant, because it can cause miscarriage or birth defects. You and your doctor will decide what blood thinner you will take while you are trying to get pregnant. You might take heparin during your pregnancy.
You are thinking about having a heart valve replaced before you get pregnant. You will have a choice of the type of heart valve you will get. The heart valve type you choose may depend on whether you plan to get pregnant in the future.
Treatments for a valve problem during pregnancy depend on the type of valve problem and how bad it is.
A procedure that widens a heart valve might be done during pregnancy if the woman develops symptoms. This procedure, called a balloon valvuloplasty or valvotomy, is done for diseases that cause a heart valve to narrow (aortic valve stenosis and mitral valve stenosis). After the woman delivers, she may then have valve repair or replacement surgery.
Other Works Consulted
Canobbio MM, et al. (2017). Management of pregnancy in patients with complex congenital heart defects: A scientific statement for healthcare professionals from the American Heart Association. Circulation, 135(8): e50-e87. DOI: 10.1161/CIR.0000000000000458. Accessed
March 2, 2017.
Nishimura RA, et al. (2014). 2014 AHA/ACC guideline for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation, published online March 3, 2014. DOI: 10.1161/CIR.0000000000000031. Accessed May 1, 2014.
ByHealthwise StaffPrimary Medical ReviewerRakesh K. Pai, MD, FACC - Cardiology, ElectrophysiologyMartin J. Gabica, MD - Family MedicineElizabeth T. Russo, MD - Internal MedicineAdam Husney, MD - Family MedicineSpecialist Medical ReviewerMichael P. Pignone, MD, MPH, FACP - Internal Medicine
Current as ofOctober 5, 2017
Current as of:
October 5, 2017
Rakesh K. Pai, MD, FACC - Cardiology, Electrophysiology & Martin J. Gabica, MD - Family Medicine & Elizabeth T. Russo, MD - Internal Medicine & Adam Husney, MD - Family Medicine & Michael P. Pignone, MD, MPH, FACP - Internal Medicine
To learn more about Healthwise, visit Healthwise.org.
© 1995-2017 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.
6051 US Hwy. 49
Hattiesburg, MS 39401
130 Highland Parkway
Picayune, MS 39466
27 B South 6th Street
Bay Springs, MS 39422
CONNECT WITH FORREST HEALTH
Notice of Privacy Practices · PUBLIC RECORDS REQUEST · FINANCIAL ASSISTANCE · NON-DISCRIMINATION NOTICE
REQUEST FROM LAW ENFORCEMENT FOR RELEASE OF PROTECTED HEALTH INFORMATION 6051 US HIGHWAY 49, HATTIESBURG MS 39401 · 601-288-7000 · © FORREST HEALTH · ALL RIGHTS RESERVED ·